Skip to content

Cemex

US · CX #1198 by market cap Listed 1970
9.59 -0.33 -3.33%
Live - 5344 symbols - heartbeat 152s ago · 2026-10-08 07:52
Pre-market 9.39 -2.09%
After-hours 9.59 0.00%
Overnight 9.58 -0.10%
Market cap
13.84B
P/B
1.06
EPS
0.65
Reader sentiment Are you bullish or bearish on CX?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Barclays Maintains Cemex(CX.US) With Buy Rating, Raises Target Price to $16
    Market Newswire · 2026/7/24
  • Rating change
    Scotiabank Maintains Cemex(CX.US) With Buy Rating, Maintains Target Price $14.5
    Market Newswire · 2026/7/24
  • Rating change
    BofA Securities Maintains Cemex(CX.US) With Buy Rating, Maintains Target Price $14.75
    Market Newswire · 2026/7/7
  • Company notice
    Zeta: ZETA and Channel Corporation have launched a business partnership in the generative AI space and begun service integration between the “ZETA CX Series” and “Channel Talk.”
    JPX · 2026/2/10
  • J.P. Morgan Maintains Cemex(CX.US) With Buy Rating, Maintains Target Price $15
    Market Newswire · 2026/9/2
  • Yomiuri: Mazda's New CX-5 Off to Great Start in Japan, but Struggling in U.S.
    Dow Jones · 2026/9/10
  • Company notice
    IRidge: In the AI era, apps are shifting from “operation” to “conversation.” We’re now offering “NEW CX READY,” which enables ultra-fast real-world deployment of prototypes.
    JPX · 2026/1/29
  • Company notice
    Mobilus: AI agent platform Vottia collaborates with Techmatic. AI utilizes CRM data in real time to automatically complete customer support and achieve both CX improvement and work efficiency
    JPX · 2025/11/7
  • Rating change
    RBC Capital Initiates Cemex(CX.US) With Hold Rating, Announces Target Price $13.5
    Market Newswire · 2026/7/24
  • FDA Says Aware Boston Scientific Issued Letter To Affected Customers Recommending Unused Infinion CX Leads Be Removed From Where They Are Used/Sold; As Of May 27, 2026, Boston Scientific Reported 1,081 Serious Injuries And No Deaths Associated With...
    Benzinga · 2026/9/4
  • Rating change
    BofA Securities Maintains Cemex(CX.US) With Buy Rating, Raises Target Price to $15
    Market Newswire · 2026/7/24
  • Cemex(CX.US) Officer Sells US$8.88 Million in Common Stock
    Market Newswire · 2026/10/1
  • Goldman Sachs Maintains Cemex(CX.US) With Buy Rating, Raises Target Price to $15.5
    Market Newswire · 2026/8/5
  • Company notice
    istyle: We have launched a “data-driven solution” to support data-driven decision-making in the beauty industry. A new company was established in collaboration with a CX consulting firm
    JPX · 2025/4/9
  • Company notice
    Mobilus: FANCL uses Mobils' CX strategy support for the purpose of improving customer service satisfaction. LINE and web chat operations are self-propelled, and work time is reduced by one-third in collaboration with FAQ
    JPX · 2025/2/13
  • Rating change
    J.P. Morgan Maintains Cemex(CX.US) With Buy Rating, Raises Target Price to $15
    Market Newswire · 2026/7/8
  • Rating change
    Barclays Maintains Cemex(CX.US) With Buy Rating, Maintains Target Price $15
    Market Newswire · 2026/7/14
  • Rating change
    RBC Capital Maintains Cemex(CX.US) With Hold Rating, Raises Target Price to $13.5
    Market Newswire · 2026/7/24
  • Rating change
    Scotiabank Maintains Cemex(CX.US) With Buy Rating, Raises Target Price to $14.5
    Market Newswire · 2026/7/15
  • Rating change
    Citi Maintains Cemex(CX.US) With Hold Rating, Raises Target Price to $13
    Market Newswire · 2026/7/4

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:52:24 · For reference only, not investment advice and not tailored to your situation.